A Covid vaccine effectiveness study that the CDC's acting director had blocked was published in an external journal in June 2026, finding that vaccines cut severe illness risk by roughly half among healthy adults over the winter. The study's publication after being blocked raises questions about decision-making processes within the CDC leadership during a period of ongoing scrutiny over vaccine communications. The research itself aligns with established scientific consensus on vaccine effectiveness, but the blocking and subsequent external publication suggest internal disagreement over how vaccine data should be communicated publicly.